| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |